If corporations own the seeds of almost everything we eat, why hasn’t anyone managed to do the same thing to cannabis?
Until now, cannabis has lived in a kind of legal and cultural side universe where the usual machinery of seed monopolies never fully clicked into place. That universe is ending. The changes converging around 2026, especially the shift to regulating seeds by THC potential and the slow march toward rescheduling, represent the first plausible structural opening for a Monsanto-style player in weed.
To see what might happen, I have to start with why it hasn’t happened yet.
How Weed Escaped Monsanto While Everything Else Got Captured
The commercial seed market has been growing steadily since the 1990s, driven by deep changes in intellectual property regimes at the core of contemporary capitalism—changes that are hard to fully unpack in a short article. By 2025, the global commercial seed market is already worth north of $80 billion a year and is on track to reach $130–150 billion before the decade is over. While for centuries seeds circulated largely free of modern legal constraints, a large portion of today’s food system now runs on proprietary genetics: patented hybrids in corn and soy, licensed varieties in vegetables, and stacked traits in cotton. Consolidation in the seed sector means that a handful of international firms—such as Bayer (which absorbed Monsanto following its acquisition of the company in 2018), Corteva, Syngenta, and a small supporting cast—control huge portions of the market.
Cannabis, meanwhile, has exploded into its own industrial universe. In the United States alone, regulated adult-use and medical sales were around $31.5 billion in 2025, with forecasts suggesting the national market will approach $40 billion by the end of the decade. Globally, the legal cannabis market is already in the $70 billion range and is projected to …
Read More
Author: Rolando García / High Times
